New antibody fragments light up tumors in early imaging trial
Knowledge-focused
Recruiting now
This early-phase trial is testing two new antibody fragments that are designed to attach to a sugar molecule found on many solid tumors. The fragments are labeled with a radioactive tracer so they can be seen on PET/CT scans. The study aims to see where these fragments go in the …
Phase: EARLY_PHASE1 • Sponsor: Var2 Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC